Genkyotex is the leading biopharmaceutical company in NOX therapies, listed on the Euronext Paris and Euronext Brussels markets. Its unique therapeutic approach is based on a selective inhibition of NOX enzymes that amplify multiple disease processes.

Location

16, Chemin des Aulx, 1228 Plan-les-Ouates, Switzerland

Facts & figures
  • Type of organization
    Public company
  • Year of foundation
    2006
Key business